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It is currently unclear whether tissue changes sur-
rounding multifocal epithelial tumors are a cause or
consequence of cancer. Here, we provide evidence
that loss of mesenchymal Notch/CSL signaling
causes tissue alterations, including stromal atrophy
and inflammation, which precede and are potent
triggers for epithelial tumors. Mice carrying a mesen-
chymal-specific deletion of CSL/RBP-Jk, a key
Notch effector, exhibit spontaneous multifocal kera-
tinocyte tumors that develop after dermal atrophy
and inflammation. CSL-deficient dermal fibroblasts
promote increased tumor cell proliferation through
upregulation of c-Jun and c-Fos expression and
consequently higher levels of diffusible growth
factors, inflammatory cytokines, and matrix-remod-
eling enzymes. In human skin samples, stromal fields
adjacent to multifocal premalignant actinic keratosis
lesions exhibit decreased Notch/CSL signaling and
associated molecular changes. Importantly, these
changes in gene expression are also induced by
UVA, a known environmental cause of cutaneous
field cancerization and skin cancer.
INTRODUCTION
Squamous cell carcinomas are very common malignant tumors
in humans, occurring in organs, such as skin, oral mucosa and
upper digestive tract, lung, and urogenital apparatus. Analysis
of these tumors led, more than 60 years ago, to the concept of
field cancerization, based on the frequent tumor multiplicity
and associated changes of both epithelial and mesenchymal
tissues beyond the neoplastic area (Slaughter et al., 1953).
Genetic and epigenetic changes of the epithelium have beenimplicated as likely primary determinants of the field canceriza-
tion process (Chai and Brown, 2009), whereas alterations of
the underlying mesenchyme have received relatively little
attention. The reasons for stromal alterations, including wide-
spread atrophic changes (Slaughter et al., 1953), are also not
understood.
Notch signaling is a form of cell-cell communication with a key
role in development and tissue homeostasis (Artavanis-Tsako-
nas et al., 1999). The mammalian Notch gene family codes for
four closely related transmembrane receptors, whose activation
depends on similar mechanisms of ligand binding, proteolytic
cleavage and nuclear translocation (Kopan and Ilagan, 2009).
The activated Notch intracellular domain associates with the
DNA binding protein CSL (CBF-1 in human and RBP-Jk in
mouse) converting it from a repressor into an activator of tran-
scription (Kopan and Ilagan, 2009). WhereasNotch-independent
functions of CSL have also been reported, loss-of-function
experiments have indicated that, in most mammalian systems,
CSL functions mainly as a Notch effector (Kopan and Ilagan,
2009).
The biological function of Notch/CSL is highly context depen-
dent. In the skin, this pathway plays a well-established function
in keratinocyte differentiation and tumor suppression through
both intracellular and paracrine growth control mechanisms
(Demehri et al., 2009; Dotto, 2008; Restivo et al., 2011; Watt
et al., 2008; Williams et al., 2011). By contrast, the role of this
pathway in the mesenchymal compartment of the skin has
been explored to a very limited extent. We show here that
mesenchymal loss of the CSL/RBP-Jk gene is sufficient to
induce in the skin several features associated with field cancer-
ization, which are amenable to increased AP1 levels and activity.
These findings are of likely clinical significance, as suppression
of Notch/CSL signaling and associated gene expression
events occur in stromal fields adjacent to cutaneous premalig-
nant actinic keratosis lesions and can be induced by UVA expo-
sure, a major cause of skin chronic and cancer-predisposing
alterations.Cell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc. 1207
Figure 1. Mesenchymal CSL/RBP-Jk Deletion Results in Spontaneous Skin Tumor Formation
(A) Overview of multiple spontaneous skin tumors in a mouse with mesenchymal RBP-Jk deletion (ColI-Cre x RBP-JkloxP/loxP) at 4 months.
(B) Low and high magnification histological images of spontaneous tumors and surrounding skin in 4-month-old mice. Tumors at this stage exhibited features of
in situ carcinomas of keratoacanthoma and/or Bowen’s disease type, with disrupted epidermal architecture, parakeratotic nuclei and foci of aberrant kerati-
nization. Immunohistochemical analysis of tumor stromal component is shown in Figures S1A and S1D.
(C) Number of tumor-bearing mice with mesenchymal RBP-Jk deletion (/) versus littermate controls (+/+) until 18 weeks after birth or earlier if mice had to be
sacrificed because of tumor burden. Fraction of males and females was similar, with no differences in tumor formation.
(D) Number of independent (physically separated) tumors in mutant mice. Shown are average tumor numbers per mouse per time point, as well as variation
among individual mice. Values may be underestimated because of coalescence of individual lesions.
(E) Histology of skin tumors in mice at 6 months of age. Higher magnification analysis showed loss of epidermal architecture, pronounced cellular atypia, and
inflammatory infiltration (Figure S1B). Lesions with similar characteristics were found in 7 of 7 mice that survived until this age. Tumors were classified as well to
moderately differentiated SCCs (Grade I-II).
(F) Immunohistochemical analysis with anti-Pankeratin antibodies showing invading epithelial islands and tumor front in a 6-month-old mouse. Quantification of
results is provided in Figure S1C.
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RESULTS
Spontaneous Multifocal Keratinocyte Tumors in Mice
with Mesenchymal CSL/RBP-Jk Deletion
We recently reported that maintenance of the hair follicle kerati-
nocyte cell fate is compromised in mice with mesenchymal
deletion of the CSL/RBP-Jk gene (ColI-Cre x RBP-Jk loxP/loxP)
because of intrinsically defective dermal papilla cells (Hu et al.,
2010). These same mice, by 2–4 months after birth, spontane-
ously developed multiple keratinocyte tumors histologically
resembling squamous cell carcinoma (SCC) precursor lesions
of the actinic keratosis/Bowen’s disease type (Figures 1A–1D;
Figure S1A available online). These lesions were characterized
by irregular architecture/expansion of the epidermis, acanthosis,
dyskeratosis, and several features of incipient malignant
disease, including discontinued laminin basement membrane
deposition, coexpression of epithelial and mesenchymal
markers, and microinvasion (Figures 1A and 1B and data not
shown). Tumor stroma alterations included expression of
cancer-associated fibroblast (CAF) markers (S100A4, alpha
Smooth Muscle Actin) and cancer-associated matrix proteins
(Tenascin C, Periostin) with a gradient of expression (Figures
S1A and S1D). Increased matrix metalloprotease levels and
inflammatory infiltrates were also observed (data not shown).
In 6-month-old mice, tumors exhibited features of malignant
SCCs, with aberrant keratinization, pronounced dysplasia and
inflammatory infiltration, and invasion of epithelial islands or
spindle-shaped cells into dermis and connective tissue (Figures
1E, 1F, S1B, and S1C). Tumors could be successfully trans-
planted (data not shown).
DNA analysis of dissociated tumor cells separated from
surrounding stroma showed neither the deletion of the RBP-Jk
gene nor mutations in the p53 and Ha-, Ki-, and N-ras genes
(Figures S1D and S1E and data not shown). Comparative
genomic hybridization (CGH) revealed small chromosomal
aberrations in all examined tumors (Figure 1G and Table S1A).
Chromosomal alterations in tumors from the same mice were
only partially overlapping, pointing to multifocal origin or sepa-
rate clonal evolution, whereas specific chromosomal regions
were similarly affected in tumors from different mice (Figure 1G
and Table S1A). These regions and/or their human equivalents
have been implicated in cancer development, most frequently
epithelial, like murine 7qC (human 15q11.2) and 8qA1.3 (Table
S2). qPCR confirmed alterations of these regions in the CGH-(G) Summary of CGH DNA analysis of skin tumors versus unrelated normal tissu
regions that were duplicated (+), deleted (), or, for pairs of tumors derived from t
provided in Table S1A. Statistical permutation tests showed that the repeated
instance, for 7qC and 8qA) is highly significant (p = 0.0005).
(H) (Upper) Map of mouse chromosomal 7qC region and overlapping segment
chromosomal regions with overlapping alterations in multiple tumors are provided
for CGH was performed with primers for three sites within the 7qC region (indica
normalization for an unrelated chromosomal region (15qB3.1). Similar results we
13qB1; data not shown). Further qPCR analysis showed duplications of the 7qC
were analyzed, from three more mice (See additional data in Table S1B).
(I and J) qRT-PCR analysis of LCM samples from tumors versus flanking norma
Tenascin C antibodies, as shown in Figure S1D) from two mice, two tumors per
normalization. Analysis of other genes is in Figure S1F. *p < 0.01 by one-way AN
Scale bars: 200 mm for (B) and (D); 40 mm for (C) and (E). Error bars represent staanalyzed tumors and/or tumors from additional mice (Figure 1H
and Table S1B).
For insights into gene expression, we used laser capture
microdissection (LCM) of spontaneously occurring tumors in
parallel with normal epidermis from the same mice. Expression
of ATF3, an AP1-related transcription factor with a positive role
in keratinocyte tumorigenesis (Wu et al., 2010), was increased
in all LCM-dissected tumors (Figure 1I), whereas growth-
inhibitory genes, like TGF-b family members p15Ink4b, p16Ink4a,
p21WAF1/Cip1, and Notch1, were downmodulated (Figure 1J).
Among positive growth regulatory genes, c-Myc, cyclin D1,
CDK4, CDK6, E2F1, p63-related, and Wnt-related genes were
not upregulated or even decreased, and, consistent with the
complex role of NF-kB signaling in keratinocytes (Hinata et al.,
2003), members of this family were differentially modulated
(Figure S1F).
Early Skin Changes in Mice with Mesenchymal
CSL/RBP-Jk Deletion
Stromal atrophy was linked with field cancerization in the initial
clinical report (Slaughter et al., 1953). Decreased dermal thick-
ness and reduced elastic fibers and collagen content were found
in skin of mutant mice at birth, when hair follicle are still normal
(Hu et al., 2010) (Figures 2A–2C, S2A, and S2B) and at 3 weeks
of age, in regions of conserved hair follicle structure and density
and when both mutant and control mice had entered the telogen
phase of the hair cycle (Figures 2A, S2A, and S2C). Collagen I
and Elastin mRNA expression was unaffected (data not shown),
whereas Collagen I protein levels were reduced in skin of mutant
mice, with increased ratio of soluble versus insoluble forms
(Figure 2D). Consistent with a proteolytic mechanism, mutant
mice had elevated dermal MMP activity already at birth (Fig-
ure 2E). Expression of a CAF marker, Periostin, but not Tenascin
C, was also increased in these mice at this time (Figure S2D and
data not shown). Dermal fibroblasts density and proliferative
index were similar to controls, with lower apoptosis (Figures
S2E–S2G).
BrdU labeling indicated that proliferation of interfollicular ker-
atinocytes was already increased in postnatal day (P) 0 mutant
mice (Figure 2F). This was accompanied by increase of phos-
phorylated activated form of Fibroblast Growth Factor Receptor
1, which occurred already inmutant embryonic day (E) 16.5–18.5
embryos (Figures 2G and 2H) together with augmented expres-
sion of mitogenic FGFs by underlying dermal fibroblasts (showne (brain) from the same mice. For each tumor are listed specific chromosomal
he same mouse, unaffected (N). Raw CGH data and statistical significance are
identification of four overlapping rearrangements in five mice (as found, for
s of duplication (green bars) in the indicated multiple tumors. Maps of other
in Table S1A. (Lower) qPCR analysis of tumor and normal DNA samples utilized
ted by arrows in the previous panel). Results are in arbitrary units after internal
re obtained after normalization for two other chromosomal regions (5qC1 and
and 8qA regions in four and five additional tumors, respectively, out of six that
l epidermis (identified by double immunofluorescence with anti-K14 and anti-
mouse. Expression of indicated genes is in arbitrary units utilizing b-Actin for
OVA followed by Bonferroni’s test.
ndard deviation (SD) of the mean.
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Figure 2. Early Skin Defects in Mice with Mesenchymal CSL/RBP-Jk Deletion
(A) Dermal thickness (distance between dermal-epidermal junction and panniculum carnosum; double end arrows in Figure S2A) was quantified in five RBP-Jk
mutant mice and five controls (black and white bars) at 4 days and 3 weeks of age (*p < 0.01). Histological images are in Figure S2A.
(B) Verhoeff-Masson-trichrome staining and quantification of elastic fibers (3105/mm2) in back skin dermis of two P4 mice per genotype, counting three inde-
pendent fields for each section (*p < 0.01).
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below). Loricrin, a differentiationmarker important for skin barrier
function, was downmodulated in mutant E16.5–E18.5 embryos
and P0 mice (Figure 2I), with increased transepidermal water
loss (TEWL) at birth that normalized in later days (Figure S2H).
LCM, followed by qRT-PCR, showed loss of RBP-Jk expres-
sion in mutant embryos dermis, with no decrease in epidermis
(Figure S2I). Parallel qRT-PCR analysis confirmed decreased
Loricrin expression in epidermis of mutant embryos and P0
mice, with similar downmodulation of another late differentiation
marker, SPRR1a (Figure 2J). RT-PCR analysis showed also
deregulation of many growth factors and cytokines in epidermis
of mutant embryos and mice, which may contribute to their later
phenotype (Figure 2J).
Role of Inflammation in Spontaneous Skin Tumor
Development
Inflammation is an important determinant of chronic tissue
alterations leading to cancer. Inflammatory cells, identified by
anti-CD45 staining, became detectable in dermis of mutant
mice a few days after birth, followed by localized inflammatory
infiltrates and concomitant expression of Tenascin C and, in
overlying epidermis, Keratin 6, a marker of epidermal hyper-
plasia (Figure 2K). Foci of inflammatory infiltrates and Tenascin
C and Keratin 6 expression expanded significantly in subsequent
days (Figure 2K), together with recruitment of macrophages
(Figures 2K and 2L). LCM of stromal tissue followed by qPCR
showed similar levels of RBP-Jk gene deletion in unaffected
versus focally altered areas (Figure S2L), pointing to the impor-
tance of more indirect events.
For wider view of skin than permitted by immunohistochemical
analysis, we adopted a technique, Fluorescence Diagnosis (FD),
used in the clinic for imaging of hyperplastic, premalignant, and
malignant keratinocytic lesions (Krammer and Plaetzer, 2008).
FD is based on preferential uptake of 5-aminolevulinic acid
(5-ALA) by hyperproliferative cells and conversion into porphy-
rins detectable by fluorescence excitation. Relative to littermate
controls, back skin of mutant mice already exhibited stronger
and widespread FD signal at birth (Figure 3A), consistent with(C) Masson-trichrome staining of total collagen in P4 mouse skin (blue) with Nuc
genotype. Collagen I and III immunostaining is in Figure S2B.
(D) Biochemical quantification of total collagen and ratio of soluble versus inso
*p < 0.01.
(E) In situ zymography of P4 mouse skin with MMP3 and MMP13 preferential sub
not shown). MMP activity in epidermis and hair follicles is likely due to diffusion, c
fibroblast compartment of RBP-Jkmutant mice (Figure S4A and data not shown
also observed by immunohistochemistry (data not shown).
(F) P0 mice were injected with BrdU, followed by BrdU labeling determination in
(G) Immunofluorescence of back skin sections of E16.5 and E18.5 embryos and P
FGFR1 and, to a less extent, other FGF receptors. Images are representative of
(H) Phospho-FGFR immunofluorescence signal intensity in epidermal compartm
(I) Immunofluorescence of back skin sections of E16.5 and E18.5 embryos a
3–4 independent fields, two mice per genotype.
(J) Epidermal compartment of E16.5 and E18.5 embryos and P0 mice was analy
shown as heat map fold changes of expression of indicated genes in mutant ver
(K) Immunofluorescence analysis of P6 and P10 mouse back skin, illustrating fo
expression. Parallel immunofluorescence with anti-K6 and F4/80 antibodies illus
(L) Quantification of focal lesion size (CD45-positive areas demarked by arrows in
five lesions per mouse, two mice per time point, were analyzed (p* < 0.01).
Scale bars: 20 mm for (A), (C), (G), and (I); 200 mm for (E) and (K). Error bars repreincreased keratinocyte proliferation detected by BrdU labeling
(Figure 2F). Discrete regions of higher FD positivity, likely
corresponding to foci of inflammatory infiltration and epidermal
hyperplasia, were also found, which increased in number over
time, eventually coalescing and marking areas of multifocal
tumor development (Figures 3A and 3B).
To assess the role of inflammation, (ColI-Cre xRBP-Jk loxP/loxP)
mice were treated with Celebrex, a broad anti-inflammatory
agent and COX-2 inhibitor. When treatment was started at birth,
strength and expansion of FD signal, as well as eventual tumor
formation, were significantly counteracted, even if not totally
suppressed (Figures 3C, 3D, and S3A). By contrast, no such
effects were observed when the treatment was initiated after
tumor development (Figure S3B), consistent with the chromo-
somal alterations that have occurred by this time and findings
that suppression of inflammation can prevent but not reverse
tumorigenesis (Colotta et al., 2009).
Tumor-EnhancingMechanisms ofCSL-Deficient Dermal
Fibroblasts
Full-thickness grafting of skin of mice with the mesenchymal
CSL/RBP-Jk deletion onto immuno-compromised animals re-
sulted in similar epidermal hyperproliferation and underlying
dermal alterations, such as increased Tenascin C and MMP3
expression and decreased elastic fibers and collagen content.
With time, the grafts gave rise to tumors similar to those of the
original mice (data not shown).
To assess whether dermal fibroblasts with CSL/RBP-Jk dele-
tion were intrinsically endowed with tumor-promoting capability,
they were admixed with weakly tumorigenic mouse (Pam212)
(Roop et al., 1983) or human (SCC13) (Rheinwald and Beckett,
1981) keratinocyte lines, followed by injection into immune-
compromised mice at the dermal-epidermal junction, that is,
a location approximating that of malignant skin tumor formation
(Wu et al., 2010). Tumors formed in the presence of RBP-Jk/
fibroblasts were significantly larger than controls (Figure 4A),
with increased proliferation (Figure 4B) and cellularity (Figure 4C)
and decreased differentiation (Figure 4D). There was disruptionlear Fast Red for counterstaining. Images are representative of four mice per
luble fractions in 3-week-old mice. Five mice per genotype were analyzed.
strates. Little signal was observed in presence of MMP inhibitor GM6001 (data
onsistent withMMP3 andMMP13 mRNA levels being increased selectively in
). Increased MMP3 and MMP13 protein expression in skin of mutant mice was
interfollicular epidermis. Four mice per genotype were analyzed (*p < 0.01).
0 mice with antibodies recognizing the activated phospho-Tyr 653/654 form of
3–4 independent fields, two mice per genotype.
ent of above skin samples by computer-assisted quantification (p* < 0.01).
nd P0 mice with antibodies against Loricrin. Images are representative of
zed by LCM and RT-PCR arrays for cytokines and growth factors. Results are
sus control samples.
ci of leukocyte infiltration (CD45-positive) and Keratin 6 (K6) and Tenascin C
trated hyperplastic epithelium and infiltrating macrophages, respectively.
the previous panel) showing a time-dependent increase. Large skin sections,
sent SD of the mean.
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Figure 3. Expanding Multifocal Skin
Lesions and Counteracting Effects of
Anti-inflammatory Treatment as Detected
by Fluorescence Diagnosis
(A) Mice at indicated times after birth were topi-
cally treated with 5-ALA, followed by fluorescent
light excitation and digital image acquisition, using
same exposure conditions for age-matched
mutant (/) and control (+/+) animals. Fluores-
cence diagnosis (FD) signal intensity was calcu-
lated as in Troy et al. (2004) (*p < 0.01).
(B) Intense FD positivity in mouse mutant back
skin at >4 weeks of age corresponds to multifocal
areas of tumor development (areas of macro-
scopic pictures marked by dotted lines).
(C) Mice with mesenchymal RBP-Jk deletion were
treated, starting at birth, with the COX2 inhibitor
Celebrex or vehicle alone (intraperitoneal injec-
tions, 20 mg per g body weight, in DMSO, twice
weekly, five mice per group), followed by FD
analysis at indicated times.
(D) Quantification of FD signal intensity and
body surface with high FD signal (above a
threshold of 23 107 photons/s/cm2/sr for mice up
to 6 days old and 1.5 3108 photons/s/cm2/sr for
older mice) for each mouse (* < 0.01). For macro-
scopic and histological images of mice at the end
of the experiment, see Figure S3A. Error bars
represent SD of the mean.of Laminin basement membrane deposition (Figure 4E), loss of
E-Cadherin (Figure 4F), and increased MMP3 production in
surrounding matrix (Figure 4G).
An important question was whether fibroblasts with RBP-Jk
deficiency can also impact on normal keratinocytes prior to
transformation. Intradermal injection of human primary keratino-
cytes (HKCs) in combination with control fibroblasts gave rise
to large epidermal islands with tightly adherent layers of
keratinocytes and pronounced granular layer differentiation
(Figure 4H). By contrast, HKCs admixed with RBP-Jk / fibro-
blasts gave rise to islands with loosely connected keratinocytes
and signs of cellular atypia (Figure 4H), higher BrdU labeling
index (Figure 4I), and decreased expression of ‘‘early’’ differenti-
ation markers like Keratin 1 (Figure 4J). Basement membrane
laminin deposition was uneven (Figure 4K), with increased
Tenascin C and Periostin expression in surrounding stroma
(Figures 4L and 4M).
To probe into underlying mechanisms, freshly isolated fibro-
blasts from P0 mice with and without RBP-Jk deletion were
analyzed for expression of growth factors/cytokines, matrix
components, and remodeling enzymes. Growth factor genes,
such as FGF7 and 10, Igf2, and CSF-1, which promote keratino-
cyte proliferation and/or inflammation (Wagner et al., 2010;
Werner et al., 2007), were upregulated in several independent
preparations of RBP-Jk / fibroblasts versus controls (Fig-
ure S4A). Matrix metallo-proteases (MMP2, 3, 9, and 13) and
Tenascin C andPeriostinwere similarly upregulated (Figure S4A).
Expression of alpha Smooth Muscle Actin (ACTA2) and PDFG1212 Cell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc.Receptor a isoform (PDGFRa) was also enhanced, whereas
that of other CAF markers, like PDGFRb, FAP, S100A4 and
Desmin, were not affected or even decreased (Figure S4A and
data not shown). Similar modulation of gene expression was
observed with cultured dermal fibroblasts from RBPJk /
mice and fibroblasts with the ‘‘floxed’’ RBP-Jk gene after
‘‘acute’’ deletion by a Cre-expressing adenovirus (Figures S4B
and S4C). Dermal fibroblasts express both Notch 1 and 2 recep-
tors. siRNA-mediated knockdown of Notch1 and, to a greater
extent, Notch2 resulted in suppression of the canonical Hes1
target gene and concomitant upregulation of genes induced by
the RBP-Jk deletion (Figure S4D).
For further insights, we resorted to cDNA microarray analysis
of dermal fibroblasts from P0 mice plus/minus RBP-Jk deletion
in parallel with cultured dermal fibroblasts plus/minus deletion
of the ‘‘floxed’’ RBP-Jk gene by Ad-Cre. As a consequence of
RBP-Jk deletion, 381 genes were found similarly modulated.
Among significant biological processes to which upregulated
genes could be assigned were ‘‘DNA damage and Stress
Response,’’ ‘‘tissue remodeling and wound repair,’’ ‘‘vasodila-
tion,’’ and ‘‘inflammatory response’’ (Figure S4E). c-Jun/AP1
was a prominent transcription factor in the network that could
be built from the validated set of genes deregulated by RBP-Jk
deletion (Figure S4F). Involvement of various AP1 family
members was assessed further below. Other relevant genes
included mediators of cell-matrix and cell-cell interactions
(CD44, Syndecan-1 (SDC1), Hyaluronan synthase 2 (HAS2)
and Hyaluronan-mediated motility receptor (HMMR)), kinases
Figure 4. RBP-Jk-Deficient Dermal Fibroblasts Enhance Growth/Tumorigenic Behavior of SCC-Derived and Normal Primary Keratinocytes
(A) Weakly tumorigenicmouse (Pam212) or human (SCC13) keratinocyteswere admixedwith cultured (second passage) dermal fibroblasts frommice plus/minus
RBP-Jk deletion prior to injection at the dermal-epidermal junction of NMRI athymicmice.Mice were sacrificed for tumor weight determination either 1 or 8 weeks
later. Weight difference between tumor pairs in each mouse and between the two groups of tumors was highly significant (*p < 0.01).
(B) Mice as in previous panel were BrdU labeled for 2 hr prior to sacrifice, followed by determination of BrdU labeling of keratinocyte tumor cells (identified by
Keratin 14 staining) in presence of control versus RBP-Jk / fibroblasts (*p < 0.01).
(C) Histological analysis of tumors formed by SCC13 cells admixedwith dermal fibroblasts plus/minusRBP-Jk deletion 8weeks after injection. Shown are low and
corresponding high-magnification images (left and right panels, boxed areas).
(D–G) Immunofluorescence analysis of the indicated proteins in tumors formed by SCC13 cells admixedwith fibroblasts plus/minusRBP-Jk deletion. Besides the
epithelial-mesenchymal border, basement membrane of underlying blood vessels (BV) is also positive for Laminin staining (E). Dotted lines mark the epithelial-
mesenchymal junction. Nuclei were visualized by DAPI staining.
(H) Histological images of epidermal islands formed by HKCs admixed with control versusRBP-Jk/ fibroblasts 1 week after intradermal mouse injection. Note
granular layer differentiation features in epidermal islands formed in presence of control but not mutant fibroblasts.
(I) Mice as in previous panel were BrdU labeled for 2 hr prior to sacrifice, followed by determination of BrdU labeling of keratinocytes (identified by Keratin 14
staining) in the presence of control versus mutant fibroblasts (*p < 0.01).
(J–M) Immunofluorescence analysis of epidermal islands formed by HKCs together with control versus mutant fibroblasts with antibodies against indicated
proteins.
Scale bars: 40 mm for (C)–(F), (L), and (M); 20 mm for (G), (H), (J), and (K). Error bars represent SD of the mean.
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Figure 5. Dermal RBP-Jk Regulates Tumor Growth through AP1
(A) Differential expression of AP1 family members in dermal fibroblasts freshly isolated from a pool of three newborn mice (P0) plus/minus RBP-Jk deletion. qRT-
PCR results are in arbitrary values after normalization for b-Actin (*p < 0.01).
(B) Immunoblot analysis of c-Jun and c-Fos expression in freshly isolated dermal fibroblasts from a pool of three P0 mice. Densitometric scanning of autora-
diographs with normalization for g-Tubulin showed, respectively, a 2- and 1.5-fold increase of c-Jun and c-Fos expression in mutant versus control cells.
(C) Immunofluorescence analysis of c-Jun (red) expression in back skin of P0 mice. Dermal fibroblasts were identified by costaining with anti-Vimentin (green)
antibodies. Dotted lines mark dermal-epidermal borders. Additional immunofluorescence images with antibodies against c-Jun and phospho-c-Jun and results
quantification are provided in Figures S5A and S5B.
(D) Expression of indicated genes in dermal fibroblasts with RBP-Jk deletion plus/minus siRNA-mediated c-Jun knockdown, in parallel with similarly cultured
control fibroblasts (black and white bars, respectively). qRT-PCR results are expressed in arbitrary units with b-Actin for normalization (*p < 0.01). Similar results
with a second set of siRNA against c-Jun, and siRNAs against c-Fos are shown in Figures S5C and S5D. Functional consequences of knockdown of other AP1
family members are shown in Figure S5E.
(E) Immunofluorescence analysis of c-Jun expression in tumors formed 1 week after intradermal injection of SCC13 cells admixed with RBP-Jk deficient dermal
fibroblasts transfected with siRNA against c-Jun or scrambled siRNA control. Dermal fibroblasts were identified by costaining with anti-Vimentin antibodies.
Tumor-stromal border is indicated by dotted lines. Similar results were obtained by immunofluorescence analysis of the other tumors formed in presence of
dermal fibroblasts plus/minus c-Jun knockdown, and are consistent with biochemical analysis of cultured cells, showing persistent knockdown effects for at least
one week after siRNA transfection.
(F) Histological analysis of tumors formed by SCC13 cells admixed with RBP-Jk deficient fibroblasts plus/minus c-Jun knockdown as in the previous panel. To
minimize individual animal variations, mice were injected in parallel with the two combinations of cells. Shown are low and corresponding high magnification
images (left and right panels, boxed areas). In the tumor formed by SCC13 cells admixed with RBP-Jk / fibroblasts with c-Jun knockdown, pronounced
apoptosis and necrosis of cells in the more central areas resulted in tissue loss - and an empty space - at the time of cutting. Similar findings were obtained with
other four tumor pairs as shown in Figures S5F–S5I, and with five additional tumor pairs from an independent experiment (data not shown).
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(MAP2K3, MAPK6, MAPK14, Prkar2a) and trascription factors
(Ets1 and NFATc3) involved in stress and/or growth responses,
and determinants of inflammation (COX2, CSF-1, IL17RA).
Increased expression of these genes, as well as of FGF7 and
FGF10, was confirmed by LCM and qRT-PCR of dermis from
P0 mutant versus wild-type mice, and E16.5 and E18.5 embryos
(Figure S4G).
Mesenchymal loss of the PTEN gene was reported to enhance
mammary tumor development driven by transgenic oncogene
expression, with induction of a CAF phenotype that overlaps
only partially with the one caused by RBP-Jk deletion (Trimboli
et al., 2009). Given previous work linking Notch signaling to
control ofPTEN expression (Demarest et al., 2008), we examined
expression of this gene but found similar levels in mutant fibro-
blasts and controls (Figures S4A and S4B).
A common feature of many genes upregulated in RBP-Jk/
fibroblasts is that they are under positive AP1 control. Notch/
RBP-Jk signaling can function as a negative regulator of AP1
activity, also through modulation of various AP1 family members
(Chu et al., 2002; Talora et al., 2002). Consistent with these
previous findings, expression of several AP1 family members
was upregulated in dermal fibroblasts from mutant mice and
embryos (Figures 5A–5C, S4G, S5A, and S5B) and fibroblasts
with Notch1 and Notch2 knockdown (Figure S4D).
To assess which AP1 family members are more functionally
important, we evaluated the consequences of their knocked-
down expression in RBP-Jk / fibroblasts. Downmodulation
of c-Jun or c-Fos returned expression of all tested growth
factors, cytokines, matrix components, and MMPs to levels
close to control cells (Figures 5D, S5C, and S5D). Knockdown
of other AP1 family members could counteract upregulation of
MMP3 expression, whereas it had more limited effects on other
genes like Fgf7 and CSF-1 (Figure S5E).
To assess the in vivo significance of these findings, RBP-
Jk / fibroblasts transfected with anti-c-Jun siRNAs versus
scrambled controls were admixed with SCC13 cells, followed
by intradermal injection into mice. Tumors formed in the pres-
ence of RBP-Jk / fibroblasts with c-Jun knockdown had
lower weight, with pronounced apoptosis/necrosis of cells in
central areas and reduced proliferation, and enhanced differen-
tiation of cells at the periphery (Figures 5E–5H and S5F–S5I).
Differences in tumor formation were accompanied by decreased
expression of CAF markers in surrounding stroma together with
decreased MMP expression and activity (Figures 5I and 5J and
data not shown).
Relevance to Human Skin
An important question was whether downmodulation of CSL
signaling can lead to a CAF-like phenotype in human cells.
shRNA-mediated knockdown of CSL (RBP-Jk) in two indepen-
dent strains of human primary dermal fibroblasts resulted in
reduced expression of the ‘‘canonical’’ Notch targets Hes1 and(G) Mice as in (E) and (F) were BrdU labeled for 2 hr prior to sacrifice. BrdU labeling
deficient fibroblasts plus/minus c-Jun knockdown (black and white bars, respec
(H–J) Same samples were analyzed by immunostaining for Keratin 1 (H) and Te
Asterisks indicate the epithelial tumor compartment.
Scale bars: 20 mm for (C), (E), (F) (right two panels), and (H)–(J); 200 mm for (F) (leHes5, as well as of Notch1 and 2 receptors, and Notch ligands
Jagged 1 and 2 (Figures 6A and S6A). Expression of c-Jun
and c-Fos, and many other genes upregulated in mouse RBP-
Jk / cells, was similarly affected in human dermal fibroblasts
with CSL knockdown (Figures 6A, S6A, and S6B). As in xeno-
grafts with mouse fibroblasts, SCC13 cells admixed with human
dermal fibroblasts with CSL knockdown formed tumors of
greater size and cellularity and more disordered differentiation
than the controls, with upregulation of Tenascin C and Periostin
expression in surrounding stroma (Figures 6B–6D and S6C and
data not shown).
To assess the relevance of the above findings to the clinical
situation, we used LCM of surgically excised skin samples
from patients with lesions preceding SCC formation. Analysis
of stroma underlying areas of premalignant lesions (actinic kera-
tosis, AK) along with skin fields farther away, revealed consistent
inverse relation between expression of Notch receptors, Hes1
and Hes5 versus c-Jun, c-Fos and other genes under negative
Notch/CSL control, like CAF markers, CD44 and COX-2, in the
lesion-underlying stroma (Figure 7A). The LCM and qRT-PCR
results were further validated by immunofluorescence analysis
of excised skin regions, showing decreased Notch2 signal inten-
sity with concomitant upregulation of c-Jun in the Vimentin-posi-
tive cells of the AK-underlying stroma versus flanking skin
(Figures 7B and S7A–S7C).
UV light exposure is a major etiopathological agent of prema-
lignant and malignant skin cancer formation (Rittie´ and Fisher,
2002). Whereas UVB has limited penetration power and its
effects are mostly limited to epidermal cells, UVA can also
directly affect cells of underlying dermis. UVA—but not UVB—
irradiation of human skin explants followed by LCM of upper
dermal compartment and qRT-PCR showed significant down-
modulation of Notch1, Notch2, and Hes1 genes even at lowest
doses, whereas c-Jun expression was upregulated (Figure 7C
and data not shown). In time-course experiments, modulation
of these genes occurred as early as 1 hr after UVA exposure
and persisted for up to 5 days (Figures 7C and S7D—S7F).
For further insights, we focused on the Notch2 gene. As with
skin explants, downmodulation of this gene, and upregulation
of c-Jun, occurred in three independent strains of cultured
human dermal fibroblasts, within 200 of UVA exposure, persisting
up to 5 days (Figure S7G and data not shown). Nascent Notch2
transcripts, detected by qRT-PCR of the first exon-intron junc-
tion, were also downregulated at late times of UVA exposure
as mature transcripts (Figure S7G). Persistent downmodulation
would be consistent with a permanent modification of the
Notch2 transcription locus. In fact, PCR analysis of methyla-
tion-enriched DNA samples from dermal compartment of skin
explants and cultured dermal fibroblasts indicated that the GC-
rich region of the Notch2 promoter was increasingly methylated
as a function of time after UVA exposure, with no increasedmeth-
ylation of a distal GC-rich region of the same gene (Figures 7Dof tumor keratinocytes (identified by Keratin 14 staining) admixed with RBP-Jk
tively) was determined in parallel with tumor weight (*p < 0.01).
nascin C (I) and in situ zymography with a preferential MMP13 substrate (J).
ft two panels). Error bars represent SD of the mean.
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Figure 6. Tumor-Enhancing Phenotype of Human Dermal Fibroblasts with CSL Knockdown
(A) Human dermal fibroblasts (HDFs) were infected with two anti-CSL shRNA lentiviral vectors (#1 and 2; black bars) in parallel with empty vector control (white
bar), followed by 6 days selection for puromycin resistance. Cells were analyzed by qRT-PCR for indicated genes, using 36b4 for normalization (*p < 0.01).
Analysis of an independent strain of HDFs plus/minus CSL knockdown is shown in Figures S6A and S6B.
(B) SCC13 keratinocytes were admixed with HDFs plus/minus CSL knockdown (by shRNA vector #1) prior to intradermal injection into NMRI athymic mice. Each
mouse received parallel injections of keratinocytes admixed with control versus CSL knockdown fibroblasts (white and black bars, respectively). Mice were
sacrificed for tumor weight determination 8 weeks later (*p < 0.01).
(C) Histological analysis of tumors formed by SCC13 cells admixed with HDFs plus/minus CSL knockdown. Shown are low and high magnification images.
Histological analysis of other tumors is shown in Figure S6C.
(D) Immunofluorescence analysis of tumors from the above experiment with antibodies against indicated proteins.
Scale bars: 100 mm. Error bars represent SD of the mean.and S7H). Importantly, similar differences in methylation of
the Notch2 promoter were found in the clinical situation, in
stroma underlying AK lesions versus skin fields further away
(Figure 7E).
DISCUSSION
Field cancerization is a clinical condition of major significance for
cancer recurrence and lethality, which is still poorly understood
(Chai and Brown, 2009). It can develop at various body sites,
among which the skin is the most common. Development of
mouse genetic models to probe into underlying molecular
defects would be highly desirable. The skin phenotype of mice
with mesenchymal RBP-Jk deletion presents several features
that are reminiscent of those found in field cancerization. The
clinical process is associated with a ‘‘diagnostic triad’’ of multi-
focal tumors, expanding alterations of the surrounding epithe-
lium and atrophic changes of the underlying stroma (Slaughter
et al., 1953). Among these, the stromal atrophy ofRBP-Jkmutant
mice is a feature that has not yet been observed, to our knowl-
edge, in any other mouse cancer model. The similarity to the
clinical situation of expanding multifocal lesions detected by
the fluorescence diagnosis technique is also remarkable.1216 Cell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc.The earliest biochemical alterations resulting from RBP-Jk
deletion in dermal fibroblasts include increased expression of
genes with mitogenic and/or proinflammatory function in both
fibroblasts and overlying keratinocytes. These in turn can elicit
further changes, most notably an inflammatory reaction, both
directly and through transiently compromised skin barrier func-
tion. Recruitment of inflammatory cells is followed by localized
infiltrates, possibly by an initially weak (and stochastic) signal,
which is then amplified by an immunological cascade. Locally
increased inflammation is likely to be a determining factor of
other focal changes in dermis and overlying epidermal tissue.
Inflammation is also known to increase chromosomal instability
(Colotta et al., 2009) and could thus contribute to later multifocal
tumors, which we found associated with specific chromosomal
alterations. Treatment of RBP-Jk mutant mice with a COX-2
inhibitor as anti-inflammatory agent delayed formation of focal
lesions and tumors, raising the exciting prospect that, even in
patients with field cancerization, inhibition of inflammation,
even if not sufficient to reverse tumorigenesis, could be used
to prevent or retard secondary tumor development. In line with
this possibility is our other finding that COX-2 expression is up-
regulated in both mouse and human fibroblasts by loss of
CSL/RBP-Jk function and in the clinical situation, in stroma
underlying actinic keratosis lesions versus skin fields further
away.
Similar changes in gene expression were elicited by loss or
downmodulation of the CSL gene and knockdown of Notch1
and Notch2. These included upregulated expression of several
AP1 family members. Consistent with their shared key role
(Eferl and Wagner, 2003), downmodulation of c-Jun or c-Fos
had the most significant effects in RBP-Jk deficient fibroblasts,
reverting expression of all tested deregulated genes. Even
in vivo, the tumor-enhancing effects of RBP-Jk / fibroblasts
were counteracted by the c-Jun knockdown. Importantly,
an inverse relationship between Notch/CSL activity and c-
Jun/c-Fos expression was also found in excised skin samples
from enrolled patients with cutaneous field cancerization, in
stromal fields underlying actinic keratosis versus distant normal
epidermis.
Basal level of Notch activity in dermal cells (as also observed
by use of a reporter mouse; our unpublished observations) can
be explained by concomitant expression of Notch receptors
and ligands by the same or neighboring cells. In the present
context, we were concerned with exogenous signals that cause
downregulation of this pathway. Cutaneous field cancerization
usually develops in sun-exposed areas in elderly people or
immunosuppressed patients and is defined by the appearance
of multiple actinic keratosis lesions on damaged skin. UVA light
exposure can directly affect the dermis, and its importance in
UV-induced carcinogenesis is increasingly recognized (Ridley
et al., 2009). We have found that UVA, but not UVB, exposure
has a rapid, negative impact on expression of Notch receptors
and downstream targets in the dermis of human skin explants
and dermal fibroblasts, in parallel with c-Jun and c-Fos upregu-
lation. This is in contrast to the consequences of UVB exposure
of human epidermis and keratinocytes, which elicits a p53-
dependent upregulation of Notch1 expression as a prosurvival
and prodifferentiation reaction (Mandinova et al., 2008; Yugawa
et al., 2007).
A very early consequence of UVA exposure is production of
radical oxygen species (ROS) with consequent ligand-indepen-
dent activation of EGFR/ERK/AP1 signaling (Rittie´ and Fisher,
2002). Whereas increased ERK/AP1 activity can negatively
regulate Notch1 expression and activity (Kolev et al., 2008),
downmodulation of Notch signaling enhances AP1 activity.
Thus, a negative feedback loop between the two pathways
can be involved in the initial impact of UVA exposure on gene
expression. A concomitant attractive mechanism is provided
by epigenetic modifications, which we have found to occur
shortly after UVA exposure at level of the Notch2 promoter.
This is consistent with recent findings of a recruitment of DNA
methyltransferase I (DNMT1) and methylation of selective GC-
rich promoters in rapid response to increased ROS levels (O’Ha-
gan et al., 2011). DNA methylation of the Notch2 promoter could
account for sustained downmodulation of the gene and be of
considerable clinical significance, as we found that the Notch2
promoter is also differentially methylated in vivo, in actinic kera-
tosis underlying stroma versus skin fields further away. DNA
methyl transferase inhibitors are already approved for clinical
trials of cancer treatment (Baylin and Jones, 2011) and an
exciting possibility is that these compounds can also be em-ployed for preventing and/or reversing stromal alterations asso-
ciated with field cancerization.
EXPERIMENTAL PROCEDURES
Mice and Human Samples
Development of mice with mesenchymal RBP-Jk deletion was previously
reported (Hu et al., 2010). All mouse work was performed in accordance
with the Swiss guidelines and regulations for the care and use of laboratory
animals.
Human skin samples for primary cell preparation were obtained from ab-
dominoplasty procedures at the Department of Plastic, Reconstructive and
Aesthetic Surgery, Lausanne University Hospital (Switzerland), with patients’
and institutional approvals. Samples of actinic keratosis and SCC were ob-
tained from clinical biopsies at the Departments of Dermatology, University
of Tu¨bingen (Germany), and Zurich University Hospital (Switzerland). Parts
not needed for histological diagnosis were further processed with institutional
review board approval.
Cell and Tissue Manipulations
Conditions for culturing of cells, organ explants, viral infection, and siRNA
transfection were previously reported (Hu et al., 2010; Kolev et al., 2008; Wu
et al., 2010). Human dermal fibroblasts were prepared from the dermis of
discarded skin samples of abdominoplasty patients. Special attention was
given to remove as much as possible of adipose and deeper dermal tissues
to minimize the presence of subcutaneous preadipocytes and adipocytes.
Skin samples were cut into small pieces and digested using 3% Collagenase
I (Sigma-Aldrich) in HBSS (Ca2+ andMg2+ free), 1 gram of tissue in 2ml enzyme
solution. The mixture was incubated at 37C for 1 hr, and enzyme activity was
stopped by adding equal volume of DMEM + 10% FBS. After filtering through
a 20 mmmesh, cells were collected by centrifugation (2000 rpm for 5 minutes)
and plated at a concentration of 100,000 cells/10 cm dish. Attached cells
were washed extensively five times with warmed PBS 1 day after plating. Cells
were cultured in DMEM + 10% FBS till 60%–70% confluent before passage.
For the present study, cells at passage 5 or 6 from multiple donors were
used. UV irradiation of cells was at 60%–70% confluency.
Full thickness grafting of mouse skin (Hu et al., 2010) and intradermal tumor-
igenicity assays (Wu et al., 2010) were also as described. Detailed conditions
for cell culture and in vivo testing are provided in the Extended Experimental
Procedures. UV exposure was performed in a Bio-Link crosslinker UV irradia-
tion system (Vilber Lourmat, Cedex, France) equipped with exchangeable UVA
(375 nm) and UVB (312 nm) lamps. The exposure dosage was measured with
a portable photometer IL1400A (International Light Technologies, Peabody,
MA, USA).
For more details and skin organ culture, collagen determination, LCM, and
anti-inflammatory treatment, please see Extended Experimental Procedures.
The list of siRNAs and shRNAs used for this study is provided in Table S3.
qRT-PCR and cDNA Microarray Analysis, LCM, and Methylated DNA
Detection
Conditions for qRT-PCR, immunoblotting, and immunofluorescence and
cDNA microarray analysis were as previously described (Hu et al., 2010;
Nguyen et al., 2006). The list of gene-specific primers is provided in Table
S3. PCR arrays were from SAbiosciences (PAMM-041). LCM was performed
using an Arcturus XT microdissection system (Applied Biosystems, Carlsbad,
CA, USA) as before (Hu et al., 2010). Methylated DNA was isolated using
MethylCollector (Active Motif, Carlsbad, CA, USA) in accordance with the
manufacturer’s protocol. Recovered DNA was quantified with a Nanodrop
1000 spectrophotometer (Nanodrop) prior to qPCR analysis.
Immunodetection
Antibodies are listed in Table S3. Immunofluorescence images were acquired
with a Zeiss LSM510 meta laser scanning microscope. For quantitation of
Notch2 immunofluorescence signal, digitally acquired images for each color
channel were separately imported into ImageJ software and converted
into binary images. The numbers of pixels (representing the intensity of theCell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc. 1217
Figure 7. Downregulation of Notch Signaling in Stromal Fields adjacent to Keratinocyte Premalignant Lesions and Impact of UVA Exposure
(A) Excised skin samples from ten patients, containing, in each case, a field of normal epidermis well separated from one with actinic keratosis (AK) lesions were
utilized for LCM of the AK underlying stroma versus stroma fields further away, followed by qRT-PCR analysis of indicated genes, using 36b4 for normalization.
Results are expressed as heat map of fold changes of the indicated genes in AK-underlying stroma versus stroma further away. Expression of a less complete set
1218 Cell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc.
fluorescence signal) were measured using ‘‘Measurement’’ function. For
single-cell Notch2 signaling measurement, Vimentin-positive single cells
were selected using ‘‘Lasso Tool’’ in Photoshop Element 8.0 software (Adobe),
and the Notch2 signal were read out by histogram and calculated in Microsoft
Excel 2004 software (Microsoft).
Fluorescence Diagnosis
Newborn or adult mice (with back skin shaved 24 hr before treatment) were
topically applied 5-ALA mix (containing 10% 5-ALA w/w [Sigma-Aldrich, St.
Louis, MO, USA] in 20% DMSO solution) at a dosage of 10 mg/cm2. Three
hours later, mice were analyzed under a Xenogen IVIS-200 optical in vivo
imaging system (Caliper Life Sciences, Mountain View, CA, USA) with excita-
tion wavelength at 430 nm and emission wavelength at 640 nm, using a DSRed
filter at 1.5 cm depth and 10 s exposure time (f2). The binning setting was
2 pixels per bin and field of view (FOV) was 24. Intensity of the emitted signal
was calculated using Living Image 3.2 software (Caliper Life Sciences).
For newborn animals (P0-P6), the minimum/maximum of reading was set at
3.5 3 106/8 3 107 photons/s; for adult mice the minimum/maximum was
set at 3 3 107/3 3 108.
Array CGH
Excised skin tumors were minced into small pieces and digested in 1%
Collagenase I (Sigma-Aldrich; 37C for 1 hr) for removal of stromal tissue.
The resulting suspension was filtered through a 40 mm mesh and epithelial
fragments were used for DNA extraction, using a Wizard Genomic DNA
Purification Kit (Promega, Madison, WI, USA). Tumor DNA samples were
labeled with Cy3 and hybridized to Nimblegen mouse CGH arrays together
with Cy5-labeled normal brain DNA extracted from the same mice. Arrays
contained 2.1 million probes across the whole genome based on the MM9
genome build. CGH was according to Nimblegen protocols. Scanning with
an Agilent G2565BAMicroarray Scanner was followed by image and data pro-
cessing using Nimblescan software v.2.5.
Statistical Analysis
PRISM software (Graph Pad Software Inc.) was used to assess statistical
significance of the results, employing one-way ANOVA followed by Bonferro-
ni’s test, except for RNAi experiments for Jun B, Jun D, FosB, FosL1, FosL2,
and shRNA experiments, where Dunnett’s test was applied.of genes could be assessed in part of the cases (from patients #6–10), because of
by histological analysis of each skin sample before and after stromal removal. Onl
which, even in the AK underlying regions, were relatively free of leukocytes (localiz
contributes to observed differences in gene expression was further ruled out by qR
in purified leukocyte than fibroblast populations, with the reverse being observed
(B) Triple immunofluorescence analysis with antibodies against Notch 2 (green), c
Upper panel: low magnification image illustrating the expected pronounced expr
c-Jun upregulation in the AK lesion (yellow arrow). (Lower): higher magnification im
positive (blue) dermal fibroblasts of stromal fields underlying normal epidermis, a
Notch2 fluorescent signal masked the Vimentin signal and single channel image
Vimentin positive cells (right). For this, acquisition of digital images was followed
cell basis. Dots refer to individual measurement values (*p < 0.01). Scale bars: 200
is shown in Figures S7A–S7C.
(C) Freshly excised human skin samples placed in semisolid culture medium and
thereafter (hours, days). LCM of upper dermal region followed by qRT-PCR was
obtained in other independent experiments with human skin explants and with ex
not shown).
(D) Human skin explants exposed to indicated UVA doses were processed at var
of CpG-methylated DNA by a binding protein capture method. Methylation levels
start site) in untreated versus UVA-treated samples were assessed by qPCR, utiliz
of the Notch2 gene (+172,856 ntd position rel. to the Notch2 start site) was perfor
UVA-induced modulation. Similar analysis of UVA-exposed dermal fibroblasts is
(E) Same skin samples of the first five patients analyzed in (A) were utilized for LC
isolation of CpG-methylated DNA as in the previous panel. qPCR analysis was use
(*p < 0.01).
Scale bars: 200 mm (upper panel of B); 20 mm (lower four panels of B). Error barsACCESSION NUMBERS
Array CGH data can be accessed through the Gene Expression Omnibus
(GEO) number GSE36464. Microarray data can be accessed through the
GEO number GSE36359.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
seven figures, and three tables and can be found with this article online at
doi:10.1016/j.cell.2012.03.048.ACKNOWLEDGMENTS
We thank Drs. T. Honjo for RBP-JkloxP/loxP mice; P. Angel for Cre transgenics;
D. Hohl for the TEWL measurement apparatus; N. Traber, I. Steiner, D. Singer,
H. Janine, J.C. Stehle, and B.C. Nguyen for technical assistance; A. Balmain
for advice; and C. Missero and C. Brisken for manuscript reading. This work
was supported by grants from the Swiss National Science Foundation
(SNSF; grant 3100A0-122281/1; CRSI33-130576/1) Oncosuisse (grant
02361-02-2009), the European Union (Epistem, Sixth Framework Program,
LSHB-CT-2005-019067), and the National Institutes of Health (grants
AR39190 and AR054856 to G.P.D.), the ‘‘Gottfried und Julia Bangerter Ryner
Stiftung’’ (to R.D.), and the European Commission (grant 037627) and the
SNSF (to A.R.).
Received: August 25, 2011
Revised: March 8, 2012
Accepted: March 23, 2012
Published: June 7, 2012REFERENCES
Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. (1999). Notch signaling:
cell fate control and signal integration in development. Science 284, 770–776.
Baylin, S.B., and Jones, P.A. (2011). A decade of exploring the cancer epige-
nome - biological and translational implications. Nat. Rev. Cancer 11, 726–734.limited sample availability. Effectiveness of the LCM procedure was evaluated
y upper stromal regions immediately adjacent to the epithelium were captured,
ed instead to the deeper regions). The possibility that leukocyte contamination
T-PCR analysis, showing thatNotch1 and 2 expressionwas, if anything, higher
for other genes like c-Jun (data not shown).
-Jun (red), and Vimentin (light blue) of an excised skin sample with an AK lesion.
ession of Notch 2 in upper epidermal layers with Notch2 downmodulation and
ages for assessment of Notch 2 (green) and c-Jun (red) expression in Vimentin
transition zone and AK lesion as indicated (fields 1, 2, and 3, respectively). The
analysis was used for quantification of Notch2 versus c-Jun signal intensity in
by computer-assisted determination of fluorescence intensity on an individual
mm, (upper); 20 mm (lower). Analysis of additional AK-containing skin excisions
treated with indicated doses of UVA (J/cm2) were withdrawn at indicated times
used to assess expression of indicated genes (*p < 0.01). Similar results were
periments with cultured human dermal fibroblasts (Figures S7D–S7G and data
ious times thereafter for LCM of the upper dermal region, followed by isolation
of the Notch2 proximal promoter region (161 ntd position rel. to the Notch2
ing total input DNA for normalization. Similar analysis of a distal GC-rich region
med as equal loading control of partially methylated DNA that is not subject to
shown in (Figure S7H).
M of AK-underlying versus distal stromal (normal skin, NS) fields, followed by
d to assessmethylation levels of theNotch2 promoter and distal GC-rich region
represent SD of the mean.
Cell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc. 1219
Chai, H., and Brown, R.E. (2009). Field effect in cancer-an update. Ann. Clin.
Lab. Sci. 39, 331–337.
Chu, J., Jeffries, S., Norton, J.E., Capobianco, A.J., and Bresnick, E.H. (2002).
Repression of activator protein-1-mediated transcriptional activation by the
Notch-1 intracellular domain. J. Biol. Chem. 277, 7587–7597.
Colotta, F., Allavena, P., Sica, A., Garlanda, C., and Mantovani, A. (2009).
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic
instability. Carcinogenesis 30, 1073–1081.
Demarest, R.M., Ratti, F., and Capobianco, A.J. (2008). It’s T-ALL about
Notch. Oncogene 27, 5082–5091.
Demehri, S., Turkoz, A., and Kopan, R. (2009). Epidermal Notch1 loss
promotes skin tumorigenesis by impacting the stromal microenvironment.
Cancer Cell 16, 55–66.
Dotto, G.P. (2008). Notch tumor suppressor function. Oncogene 27, 5115–
5123.
Eferl, R., and Wagner, E.F. (2003). AP-1: a double-edged sword in tumorigen-
esis. Nat. Rev. Cancer 3, 859–868.
Hinata, K., Gervin, A.M., Jennifer Zhang, Y., and Khavari, P.A. (2003).
Divergent gene regulation and growth effects by NF-kappa B in epithelial
and mesenchymal cells of human skin. Oncogene 22, 1955–1964.
Hu, B., Lefort, K., Qiu, W., Nguyen, B.C., Rajaram, R.D., Castillo, E., He, F.,
Chen, Y., Angel, P., Brisken, C., and Dotto, G.P. (2010). Control of hair follicle
cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory
axis. Genes Dev. 24, 1519–1532.
Kolev, V., Mandinova, A., Guinea-Viniegra, J., Hu, B., Lefort, K., Lambertini, C.,
Neel, V., Dummer, R., Wagner, E.F., and Dotto, G.P. (2008). EGFR signalling as
a negative regulator of Notch1 gene transcription and function in proliferating
keratinocytes and cancer. Nat. Cell Biol. 10, 902–911.
Kopan, R., and Ilagan, M.X. (2009). The canonical Notch signaling pathway:
unfolding the activation mechanism. Cell 137, 216–233.
Krammer, B., and Plaetzer, K. (2008). ALA and its clinical impact, frombench to
bedside. Photochem. Photobiol. Sci. 7, 283–289.
Mandinova, A., Lefort, K., Tommasi di Vignano, A., Stonely, W., Ostano, P.,
Chiorino, G., Iwaki, H., Nakanishi, J., and Dotto, G.P. (2008). The FoxO3a
gene is a key negative target of canonical Notch signalling in the keratinocyte
UVB response. EMBO J. 27, 1243–1254.
Nguyen, B.C., Lefort, K., Mandinova, A., Antonini, D., Devgan, V., Della Gatta,
G., Koster, M.I., Zhang, Z., Wang, J., Tommasi di Vignano, A., et al. (2006).
Cross-regulation between Notch and p63 in keratinocyte commitment to
differentiation. Genes Dev. 20, 1028–1042.
O’Hagan, H.M., Wang, W., Sen, S., Destefano Shields, C., Lee, S.S., Zhang,
Y.W., Clements, E.G., Cai, Y., Van Neste, L., Easwaran, H., et al. (2011).
Oxidative damage targets complexes containing DNA methyltransferases,
SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 20,
606–619.1220 Cell 149, 1207–1220, June 8, 2012 ª2012 Elsevier Inc.Restivo, G., Nguyen, B.-C., Dziunycz, P., Ristorcelli, E., Ryan, R.J., O¨zuysal,
O¨.Y., Di Piazza, M., Radtke, F., Dixon, M.J., Hofbauer, G.F., et al. (2011).
IRF6 is a mediator of Notch pro-differentiation and tumour suppressive func-
tion in keratinocytes. EMBO J. 30, 4571–4585.
Rheinwald, J.G., and Beckett, M.A. (1981). Tumorigenic keratinocyte lines
requiring anchorage and fibroblast support cultures from human squamous
cell carcinomas. Cancer Res. 41, 1657–1663.
Ridley, A.J., Whiteside, J.R., McMillan, T.J., and Allinson, S.L. (2009). Cellular
and sub-cellular responses to UVA in relation to carcinogenesis. Int. J. Radiat.
Biol. 85, 177–195.
Rittie´, L., and Fisher, G.J. (2002). UV-light-induced signal cascades and skin
aging. Ageing Res. Rev. 1, 705–720.
Roop, D.R., Hawley-Nelson, P., Cheng, C.K., and Yuspa, S.H. (1983). Expres-
sion of keratin genes in mouse epidermis and normal and malignantly trans-
formed epidermal cells in culture. J. Invest. Dermatol. 81(1, Suppl), 144s–149s.
Slaughter, D.P., Southwick, H.W., and Smejkal, W. (1953). Field cancerization
in oral stratified squamous epithelium; clinical implications of multicentric
origin. Cancer 6, 963–968.
Talora, C., Sgroi, D.C., Crum, C.P., and Dotto, G.P. (2002). Specific down-
modulation of Notch1 signaling in cervical cancer cells is required for sus-
tained HPV-E6/E7 expression and late steps of malignant transformation.
Genes Dev. 16, 2252–2263.
Trimboli, A.J., Cantemir-Stone, C.Z., Li, F., Wallace, J.A., Merchant, A., Crea-
sap, N., Thompson, J.C., Caserta, E., Wang, H., Chong, J.L., et al. (2009). Pten
in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461,
1084–1091.
Troy, T., Jekic-McMullen, D., Sambucetti, L., and Rice, B. (2004). Quantitative
comparison of the sensitivity of detection of fluorescent and bioluminescent
reporters in animal models. Mol. Imaging 3, 9–23.
Wagner, E.F., Schonthaler, H.B., Guinea-Viniegra, J., andTschachler, E. (2010).
Psoriasis: what we have learned from mouse models. Nat. Rev. Rheumatol. 6,
704–714.
Watt, F.M., Estrach, S., and Ambler, C.A. (2008). Epidermal Notch signalling:
differentiation, cancer and adhesion. Curr. Opin. Cell Biol. 20, 171–179.
Werner, S., Krieg, T., and Smola, H. (2007). Keratinocyte-fibroblast interac-
tions in wound healing. J. Invest. Dermatol. 127, 998–1008.
Williams, S.E., Beronja, S., Pasolli, H.A., and Fuchs, E. (2011). Asymmetric cell
divisions promote Notch-dependent epidermal differentiation. Nature 470,
353–358.
Wu, X., Nguyen, B.C., Dziunycz, P., Chang, S., Brooks, Y., Lefort, K., Hofbauer,
G.F., and Dotto, G.P. (2010). Opposing roles for calcineurin and ATF3 in
squamous skin cancer. Nature 465, 368–372.
Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S., Fujita, M., and Kiyono, T.
(2007). Regulation of Notch1 gene expression by p53 in epithelial cells. Mol.
Cell. Biol. 27, 3732–3742.
